比较铁剂对不同心功能分级\合并贫血的心衰患者的疗效(3)
 |
| 第1页 |
参见附件(2700KB，3页)。
[2] Groenveld HF, Januzzi JL, Damman K, et al. Animia and mortality in heart failure patients:a systematic review and meta-analysis.J Am Coll Cardiol,2008,52(10):818-827.
[3] Parissis JT, kourea K, Panou F, et al. Effects of darbepoetin αon right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am Heart J,2008,155(4):751.
[4] Ponikowski P, Anker SD, Szachniewicz J, et al.Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure:a randomized, double-blind, placebo-controlled trail.J AmColl Cardiol,2007,49(7):753-762.
[5] Toblli JE, Lombrana A, Duarte P,et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol,2007,50(17):1657- 1665.
[6] Ghali JK, Anand IS, Abraham WT, et al. Study of Anemia in Heart Failure Trial (STAMINA-HeFT) Group. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation,2008,17(4):526-535.
[7] Silverberg DS, Wexlerb D, Iaina A, et al. The role of correction of anemia in patients with congestive heart failure:a short review.European Journal of Heart Failure,2008,10(9):819-823.
[8] Silverberg DS, Wexler D, Iaina A, et al. The interaction between heart failure and other heart disease and anemia. Semin Nephrol, 2006,26(4):296-306.
[9] Lindenfeld JA. Prevalence of anemia and the effects on mortality in patients with heart failure. Am Heart J, 2005,149(3):391-401 ......
您现在查看是摘要介绍页，详见PDF附件(2700KB，3页)。